½ÃÀ庸°í¼­
»óǰÄÚµå
1602735

¼¼°èÀÇ ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Anesthesia & Respiratory Devices Market by Product (Anesthesia Devices, Respiratory Devices), End-User (Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸¶Ãë ¹× È£Èí ±â±â(Anesthesia & Respiratory Devices) ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 369¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 402¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.63%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 579¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀº ȯÀÚÀÇ È£Èí°ú ¾ÈÁ¤ÀûÀÎ ¸¶Ãë Àü´ÞÀ» Áö¿ø, °ü¸® ¹× Æò°¡ÇÏ´Â µ¥ »ç¿ëµÇ´Â Àåºñ¸¦ Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¼ö¼ú, ÀÀ±Þ »óȲ ¹× ¸¸¼º Áúȯ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î, È£Èí°ï¶õÀ» °æÇèÇϰųª ÁøÁ¤ÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô Áß¿äÇÑ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Çʿ伺Àº ¼ö¼ú ÀýÂ÷ Áõ°¡, COPD ¹× õ½Ä°ú °°Àº È£Èí±â ÁúȯÀÇ ¹ßº´·ü Áõ°¡, °í·ÉÈ­¸¦ À§ÇÑ È¿À²ÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¿¡¼­ ºñ·ÔµË´Ï´Ù. Áß¿äÇÑ ÀÀ¿ë ºÐ¾ß¿¡´Â º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, °¡Á¤¿ë ÀÇ·á ȯ°æÀÌ Æ÷ÇԵ˴ϴÙ. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ÀÌ·¯ÇÑ È¯°æ¿¡ °ÉÃÄ ÀÖÀ¸¸ç, ȯÀÚ ÆíÀǼº°ú Ä¡·á ºñ¿ë Àý°¨¿¡ ´ëÇÑ Æ®·»µå¸¦ ¹Ý¿µÇÏ¿© °¡Á¤¿ë ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ °­Á¶°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº µðÁöÅÐ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ °³¹ß, Á¤¹Ð Åõ¾à ±â¼ú, ±â±âÀÇ È޴뼺 Çâ»ó°ú °°Àº ±â¼ú ¹ßÀü¿¡ ÀÇÇØ ÁÖµµµË´Ï´Ù. ƯÈ÷ ½ÅÈï °æÁ¦±Ç¿¡¼­ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå È®Àåµµ ÃËÁøµË´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ÀåÄ¡¿Í ¿ø°Ý ÀÇ·á ÅëÇÕÀº »õ·Î¿î ±âȸ¸¦ Á¦½ÃÇÏ¿© ¸¸¼º ÁúȯÀ» ´õ Àß °ü¸®ÇÏ°í ¼ö¼ú ÈÄ Ä¡·á¸¦ Áö¿øÇÕ´Ï´Ù. ±ÇÀå »çÇ׿¡´Â ¿¹Ãø ºÐ¼® ¹× °³ÀÎÈ­µÈ Ä¡·á¸¦ À§ÇØ AI¸¦ Ȱ¿ëÇÏ°í ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀ» È®ÀåÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ, ³ôÀº Çõ½Å ºñ¿ë, °³¹ß Áö¿ªÀÇ ½ÃÀå Æ÷È­µµ°¡ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ ¼Ò¿ÜµÈ Áö¿ª¿¡¼­ Á¦ÇÑµÈ Àνİú Á¢±Ù¼ºÀº »ó´çÇÑ À庮À» ÃÊ·¡ÇÕ´Ï´Ù. Çõ½ÅÀº ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÈÞ´ë¿ë ±â±â¸¦ °³¹ßÇϰí ÅëÇÕ ÀÇ·á ¼Ö·ç¼ÇÀ» À§ÇÑ ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ» °­È­ÇÏ´Â µ¥ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ºü¸¥ ¹ßÀüÀ» Ư¡À¸·Î ÇÏ´Â ÀÌ ½ÃÀåÀº Æí¾ÈÇÔ°ú ³»±¸¼ºÀ» À§ÇÑ »õ·Î¿î ¼ÒÀç¿Í ´Ù¾çÇÑ Ä¡·á ¿ëµµ¸¦ °áÇÕÇÑ ÇÏÀ̺긮µå ±â±â ±â´É¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸¸¦ ¿ä±¸ÇÕ´Ï´Ù. ÀÇ·á µðÁöÅÐÈ­ Ãß¼¼¿¡ ÀûÀÀÇÏ°í ¸ðµâÇü ¹× È®Àå °¡´ÉÇÑ ¼Ö·ç¼ÇÀÇ ¿ì¼±¼øÀ§¸¦ Á¤ÇÏ´Â °ÍÀº ÁøÈ­ÇÏ´Â ½ÃÀå ȯ°æ¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå°ú °æÀï ¿ìÀ§¸¦ Ãß±¸ÇÏ´Â ±â¾÷¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 369¾ï 3,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 402¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 579¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 6.63%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç °áÁ¤À» °³¼±Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º È£Èí±â ÁúȯÀÇ À¯Çà°ú È¿°úÀûÀÎ Ä¡·áÀÇ Çʿ伺
    • ÃÖ¼Ò Ä§½À ¹× ħ½ÀÀû ¿Ü°ú ¼ö¼ú Áõ°¡
    • ÀçÅÃÄ¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ÈÞ´ëÇü ÀÇ·á±â±âÀÇ »ç¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÇ·á±â±âÀÇ ¸·´ëÇÑ ºñ¿ë°ú Á¦Ç° ¸®ÄÝÀÇ ±ÞÁõ
  • ½ÃÀå ±âȸ
    • ¸¶Ãë ¹× È£Èí ±â±âÀÇ ±â¼úÀû Áøº¸
    • ¸¶Ãë ¹× È£Èí ±â±â ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¤ºÎÀÇ ´ëó¿Í ½ÂÀÎ
  • ½ÃÀå °úÁ¦
    • ±â¼úÀû º¹À⼺°ú Àåºñ ¿ÀÀÛµ¿ÀÇ À§Çè

Porter's Five Forces : ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¸¶Ãë ¹× È£Èí ±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº Àü ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÀÖ¾î ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü°ú È¿°úÀûÀÎ Ä¡·áÀÇ Çʿ伺
      • ÃÖ¼Ò Ä§½À ¹× ħ½À ¼ö¼ú Áõ°¡
      • ÀçÅà Äɾî¿Í ÈÞ´ë¿ë ÀÇ·á±â±âÀÇ »ç¿ë¿¡ ´ëÇÑ ÁÖ¸ñ È®´ë
    • ¾ïÁ¦¿äÀÎ
      • ±â±âÀÇ ¸·´ëÇÑ ºñ¿ë°ú Á¦Ç° ¸®ÄÝÀÇ ±ÞÁõ
    • ±âȸ
      • ¸¶Ãë ¹× È£Èí ±â±âÀÇ ±â¼úÀû Áøº¸
      • ¸¶Ãë ¹× È£Èí ±â±â°è¿¡ °üÇÑ Á¤ºÎÀÇ ´ëó¿Í ½ÂÀÎ
    • °úÁ¦
      • ±â¼úÀû º¹À⼺°ú ÀåÄ¡ °íÀåÀÇ À§Çè
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå : Á¦Ç°º°

  • ¸¶ÃëÀåÄ¡
    • ¸¶Ãë °ø±Þ ½Ã½ºÅÛ
    • ¸ð´ÏÅÍ
    • ±âÈ­±â
  • È£Èí±â
    • Áö¼Ó¾ç¾ÐÈ£ÈíÀåÄ¡
    • ÈíÀÔ±â
    • ºÐ¹«±â(³×ºæ¶óÀÌÀú)
    • È£Èí ÃøÁ¤ ÀåÄ¡
    • ÀΰøÈ£Èí±â

Á¦7Àå ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ȨÄɾî ȯ°æ
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸¶Ãë ¹× È£Èí ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • ACUTRONIC Medical Systems AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BOMImed
  • CAIRE Inc.
  • Convatec Inc.
  • Dragerwerk AG&Co. KGaA
  • Fisher&Paykel Healthcare Corporation Limited
  • General Electric Company
  • Getinge AB
  • Intersurgical Ltd.
  • Koninklijke Philips NV
  • LivaNova Deutschland GmbH
  • Masimo Corp.
  • Medline Industries, LP
  • Medtronic PLC
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
  • Recipharm AB
  • ResMed Corp.
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • Stryker Corporation
  • Teleflex Inc.
LYJ

The Anesthesia & Respiratory Devices Market was valued at USD 36.93 billion in 2023, expected to reach USD 40.27 billion in 2024, and is projected to grow at a CAGR of 6.63%, to USD 57.92 billion by 2030.

The anesthesia and respiratory devices market encompasses equipment used to support, manage, and assess breathing and stable anesthetic delivery in patients. These devices are essential in surgeries, emergency settings, and chronic disease management, providing critical care to patients experiencing respiratory distress or requiring sedation. The necessity for these devices stems from increasing surgical procedures, rising incidences of respiratory diseases like COPD and asthma, and the persistent demand for efficient healthcare solutions for an aging population. Significant applications include hospitals, ambulatory surgical centers, and home healthcare settings. End-use scope spans these settings, with a burgeoning emphasis on home healthcare reflecting the trend for patient convenience and cost-reduction in treatment. Market growth is driven by technological advancements such as the development of digital monitoring systems, precise dosing technologies, and enhanced portability of devices. Increasing investments in healthcare infrastructure, especially in emerging economies, also propels market expansion. Remote monitoring devices and telemedicine integration present fresh opportunities, allowing better management of chronic conditions and aiding post-operative care. Recommendations entail leveraging AI for predictive analytics and personalized treatment, and expanding telehealth solutions. Challenges include stringent regulatory environments, high costs of innovation, and market saturation in developed regions. Additionally, limited awareness and accessibility in underprivileged areas pose significant barriers. Innovation should focus on developing cost-efficient, user-friendly portable devices and enhancing software capabilities for integrated healthcare solutions. The market, characterized by rapid advancements, demands continuous research into new materials for comfort and durability, as well as into hybrid device functionalities that combine different therapeutic uses. Staying adaptive to healthcare digitization trends and prioritizing modular and scalable solutions will be crucial for businesses seeking sustainable growth and competitive edge in the evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 36.93 billion
Estimated Year [2024] USD 40.27 billion
Forecast Year [2030] USD 57.92 billion
CAGR (%) 6.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anesthesia & Respiratory Devices Market

The Anesthesia & Respiratory Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic respiratory disorders and need for effective treatment
    • Increasing number of minimally invasive and invasive surgical procedures
    • Rising focus on homecare and use of portable medical devices
  • Market Restraints
    • High cost of the devices and surging cases of product recalls
  • Market Opportunities
    • Technological advancements in anesthesia and respiratory devices
    • Government initiatives and approval for anesthesia and respiratory systems
  • Market Challenges
    • Technical complexity and risk of device malfunctioning

Porter's Five Forces: A Strategic Tool for Navigating the Anesthesia & Respiratory Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anesthesia & Respiratory Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anesthesia & Respiratory Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anesthesia & Respiratory Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anesthesia & Respiratory Devices Market

A detailed market share analysis in the Anesthesia & Respiratory Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anesthesia & Respiratory Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anesthesia & Respiratory Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anesthesia & Respiratory Devices Market

A strategic analysis of the Anesthesia & Respiratory Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anesthesia & Respiratory Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ACUTRONIC Medical Systems AG, B. Braun Melsungen AG, Becton, Dickinson and Company, BOMImed, CAIRE Inc., Convatec Inc., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, General Electric Company, Getinge AB, Intersurgical Ltd., Koninklijke Philips N.V., LivaNova Deutschland GmbH, Masimo Corp., Medline Industries, LP, Medtronic PLC, Nihon Kohden Corporation, OSI Systems, Inc., Recipharm AB, ResMed Corp., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Group plc, Stryker Corporation, and Teleflex Inc..

Market Segmentation & Coverage

This research report categorizes the Anesthesia & Respiratory Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anesthesia Devices and Respiratory Devices. The Anesthesia Devices is further studied across Anesthesia Delivery System, Monitors, and Vaporizers. The Respiratory Devices is further studied across Continuous Positive Airway Pressure Devices, Inhalation Devices, Nebulizers, Respiratory Measurement Devices, and Ventilators.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic respiratory disorders and need for effective treatment
      • 5.1.1.2. Increasing number of minimally invasive and invasive surgical procedures
      • 5.1.1.3. Rising focus on homecare and use of portable medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the devices and surging cases of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in anesthesia and respiratory devices
      • 5.1.3.2. Government initiatives and approval for anesthesia and respiratory systems
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complexity and risk of device malfunctioning
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anesthesia & Respiratory Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Anesthesia Devices
    • 6.2.1. Anesthesia Delivery System
    • 6.2.2. Monitors
    • 6.2.3. Vaporizers
  • 6.3. Respiratory Devices
    • 6.3.1. Continuous Positive Airway Pressure Devices
    • 6.3.2. Inhalation Devices
    • 6.3.3. Nebulizers
    • 6.3.4. Respiratory Measurement Devices
    • 6.3.5. Ventilators

7. Anesthesia & Respiratory Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Homecare Settings
  • 7.4. Hospitals & Clinics

8. Americas Anesthesia & Respiratory Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anesthesia & Respiratory Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anesthesia & Respiratory Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. ACUTRONIC Medical Systems AG
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. BOMImed
  • 6. CAIRE Inc.
  • 7. Convatec Inc.
  • 8. Dragerwerk AG & Co. KGaA
  • 9. Fisher & Paykel Healthcare Corporation Limited
  • 10. General Electric Company
  • 11. Getinge AB
  • 12. Intersurgical Ltd.
  • 13. Koninklijke Philips N.V.
  • 14. LivaNova Deutschland GmbH
  • 15. Masimo Corp.
  • 16. Medline Industries, LP
  • 17. Medtronic PLC
  • 18. Nihon Kohden Corporation
  • 19. OSI Systems, Inc.
  • 20. Recipharm AB
  • 21. ResMed Corp.
  • 22. Schiller AG
  • 23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 24. Smiths Group plc
  • 25. Stryker Corporation
  • 26. Teleflex Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦